Nitric Oxide: A Putative Modulator of Muscarinic Receptor in the Airways Smooth Muscles
In 1987 nitric oxide (NO) was identified as an important endothelium-derived muscle relaxant (Ignarro et al., 1987; Palmer et al., 1987). NO, produced by the endothelium from arginine, act as a local vasodilator by diffusing into vascular smooth muscle and incorporating intracellularly with the heme present in guanylyl cyclase (Ignarro, 1989). This activates the guanylyl cyclase and results in an increased synthesis of cyclic GMP (cGMP) and consequent relaxation of smooth muscle cells.
KeywordsCatheter Attenuation Polyethylene Arginine Porphyrin
Unable to display preview. Download preview PDF.
- Barnes, P.J., 1991, Pharmacology of airways smooth muscle, in The Lung scientific foundation, R.G. Crystal, J.B. West et al. (eds.), Raven press Ltd. New York.Google Scholar
- Ignarro, L.J., 1989, Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins, Semi. Hematol., 26:63–76.Google Scholar
- Johns, R.A., Peach, M.J., Linden, J. and Tichotsky, A., 1990, NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation on cocultures of endothelial and vascular smooth muscle cells by an action specific to endothelial cell, Circ. Res. 67:979–985.PubMedCrossRefGoogle Scholar